Simultaneous determination of 3-mercaptopyruvate and cobinamide (cas 13497-85-3) in plasma by liquid chromatography–tandem mass spectrometry
-
Add time:08/15/2019 Source:sciencedirect.com
The current suite of Food and Drug Administration (FDA) approved antidotes (i.e., sodium nitrite, sodium thiosulfate, and hydroxocobalamin) are effective for treating cyanide poisoning, but individually, each antidote has major limitations (e.g., large effective dosage or delayed onset of action). To mitigate these limitations, next-generation cyanide antidotes are being investigated, including 3-mercaptopyruvate (3-MP) and cobinamide (cas 13497-85-3) (Cbi). Analytical methods capable of detecting these therapeutics individually and simultaneously (for combination therapy) are essential for the development of 3-MP and Cbi as potential cyanide antidotes. Therefore, a liquid chromatography–tandem mass-spectrometry method for the simultaneous analysis of 3-MP and Cbi was developed. Sample preparation of 3-MP consisted of spiking plasma with an internal standard (13C3-3-MP), precipitation of plasma proteins, and derivatizing 3-MP with monobromobimane to produce 3-mercaptopyruvate-bimane. Preparation of Cbi involved denaturing plasma proteins with simultaneous addition of excess cyanide to convert each Cbi species to dicyanocobinamide (Cbi(CN)2). The limits of detection for 3-MP and Cbi were 0.5 μM and 0.2 μM, respectively. The linear ranges were 2–500 μM for 3-MP and 0.5–50 μM for Cbi. The accuracy and precision for 3-MP were 100 ± 9% and <8.3% relative standard deviation (RSD), respectively. For Cbi(CN)2, the accuracy was 100 ± 13% and the precision was <9.5% RSD. The method presented here was used to determine 3-MP and Cbi from treated animals and may ultimately facilitate FDA approval of these antidotes for treatment of cyanide poisoning.
We also recommend Trading Suppliers and Manufacturers of cobinamide (cas 13497-85-3). Pls Click Website Link as below: cas 13497-85-3 suppliers
Prev:Intramuscular cobinamide (cas 13497-85-3) Sulfite in a Rabbit Model of Sublethal Cyanide Toxicity
Next:cobinamide (cas 13497-85-3) chemistries for photometric cyanide determination. A merging zone liquid core waveguide cyanide analyzer using cyanoaquacobinamide (cas 13497-85-3)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Development of a cobinamide (cas 13497-85-3)-based end-of-service-life indicator for detection of hydrogen cyanide gas08/17/2019
- cobinamide (cas 13497-85-3) chemistries for photometric cyanide determination. A merging zone liquid core waveguide cyanide analyzer using cyanoaquacobinamide (cas 13497-85-3)08/16/2019
- Intramuscular cobinamide (cas 13497-85-3) Sulfite in a Rabbit Model of Sublethal Cyanide Toxicity08/14/2019
- Intravenous cobinamide (cas 13497-85-3) Versus Hydroxocobalamin for Acute Treatment of Severe Cyanide Poisoning in a Swine (Sus scrofa) Model08/13/2019
- Inhibition of nitric oxide synthase by cobalamins and cobinamide (cas 13497-85-3)s08/12/2019
- High performance liquid chromatography tandem mass spectrometry assay for the determination of cobinamide (cas 13497-85-3) in pig plasma08/11/2019
- Comparative study of reaction of cobalamin and cobinamide (cas 13497-85-3) with thiocyanate08/10/2019
- Determination of free cyano-cobinamide (cas 13497-85-3) in swine and rabbit plasma by liquid chromatography tandem mass spectrometry08/09/2019
- Mechanistic basis of vitamin B12 and cobinamide (cas 13497-85-3) salvaging by the Vibrio species08/08/2019


